Allergy Vaccine for Grass and Cupressaceae Allergies

We are studying a new vaccine for people with allergies to grasses and cupressaceae, including those with mild to moderate asthma. The trial aims to see if this vaccine is more effective and safe than a placebo during pollen season.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Allergen Extract From Dactylis Glomerata Pollen
Allergen extract from Dactylis glomerata pollen is used to test for and reduce allergic reactions to grass pollen.
Allergen Extract From Lolium Perenne Pollen
Allergen extract from Lolium perenne pollen is a substance used to diagnose and reduce seasonal allergic reactions to ryegrass pollen.
Allergen Extract From Phleum Pratense Pollen
Allergen extract from Phleum pratense pollen is used to diagnose and reduce allergic reactions to timothy grass pollen.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Mixture of Modified Allergen Extracts
Allergenic Extract of Juniperus Oxycedrus

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Universitario Fundacion Alcorcon
Allergy
Alcorcón, Spain
Hospital Nuestra Señora de Sonsoles
Allergy
Ávila, Spain
Hospital Universitario De Burgos
Allergy
Campo de Criptana, Spain

Sponsor: Inmunotek S.L.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.